James L Labelle MD PhD
Professor Pediatrics, Section of Hematology/Oncology & Stem Cell Transplantation, University of Chicago Director, Pediatric Stem Cell and Cellular Therapy Program Interim Section Chief, Pediatric Hematology/Oncology/Stem Cell and Cellular Therapy Interim Cancer Service Line Director, Chicagoland Children's Health Alliance (CCHA)
Join to view full profile
5841 S Maryland AveChicago, IL 60637
Phone+1 888-824-0200
Fax+1 773-834-1329
Dr. Labelle is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Boston Children’s Hospital/Boston Medical CenterFellowship, Pediatric Hematology/Oncology, 2006 - 2009- Boston Children’s Hospital/Boston Medical CenterResidency, Pediatrics, 2003 - 2006
Medical College of WisconsinClass of 2003
Certifications & Licensure
IL State Medical License 2012 - 2029
MA State Medical License 2007 - 2014
American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- Low-Strength Type I Interferon Signaling Promotes CAR T-cell Treatment Efficacy.Erting Tang, Yifei Hu, Guoshuai Cao, Duy-Thuc Nguyen, Nicholas W Asby
Cancer Immunology Research. 2026-08-04 - G-CSF for Mobilizing CD34Cells in Individuals With SCD: A Word of Caution.Akshay Sharma, Allistair Abraham, Monica Bhatia, María Cancio, Sonali Chaudhury
American Journal of Hematology. 2026-06-01 - Therapeutic targeting of BCL-2 during CART cell production augments potency through non-apoptotic adaptive changes.Nada S Aboelella, Ryan Park, Erting Tang, Nicholas Asby, Joshua D Ho
Signal Transduction and Targeted Therapy. 2026-04-27
Press Mentions
State Heallth Agency Issues First Report on High-Cost Drugs, TreatmentJanuary 20th, 2025
Illinois Advances Healthcare Equity with Key Report Targeting Access to Gene and Cell Therapies for Medicaid PatientsJanuary 11th, 2025
More than 200 UChicago Medicine doctors named 'Top Docs in Cook County' by Chicago MagazineJanuary 6th, 2025
Grant Support
- Reprograming T cell function through BCL-2 family protein:protein disruptionUNIVERSITY OF CHICAGO2026–2031
- Reprograming T cell function through BCL-2 family protein:protein disruptionUNIVERSITY OF CHICAGO2026–2031
- Reprograming T cell function through BCL-2 family protein:protein disruptionUNIVERSITY OF CHICAGO2026–2031
- Reprograming T cell function through BCL-2 family protein:protein disruptionUNIVERSITY OF CHICAGO2026–2031
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: